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Abstract
Background: In all OECD countries, there is a trend to increasing patients’ copayments in order to balance rising
overall health-care costs. This systematic review focuses on inequalities concerning the amount of out-of-pocket
payments (OOPP) associated with income, education or gender in the Elderly aged 65+.
Methods: Based on an online search (PubMed), 29 studies providing information on OOPP of 65+ beneficiaries in
relation to income, education and gender were reviewed.
Results: Low-income individuals pay the highest OOPP in relation to their earnings. Prescription drugs account for
the biggest share. A lower educational level is associated with higher OOPP for prescription drugs and a higher
probability of insufficient insurance protection. Generally, women face higher OOPP due to their lower income and
lower labour participation rate, as well as less employer-sponsored health-care.
Conclusions: While most studies found educational and gender inequalities to be associated with income, there
might also be effects induced solely by education; for example, an unhealthy lifestyle leading to higher payments
for lower-educated people, or exclusively gender-induced effects, like sex-specific illnesses. Based on the
considered studies, an explanation for inequalities in OOPP by these factors remains ambiguous.
Background
In all OECD countries, there is a trend to increasing
patients’ copayments in order to balance rising overall
health-care costs [1]. Major concerns in this topic
revolve around inequalities in burden for subgroups of
society, being unproportionally charged for health care
services because of their socioeconomic background.
The difference in financial strain is displayed in a larger
share of income that must be invested in health care
services, leading to dissimilar efforts for comparable
benefits, and disadvantages for low-income beneficiaries.
There are three major forms of copayments. Firstly,
t h e r ei sav a r y i n ga m o u n tt h a tm u s tb ep a i db yt h e
patient before the insurance company steps in, called
deductible. Regularly, a higher deductible is associated
with a lower premium, leaving the beneficiary with a
lower basic amount, but at higher risk in case of mor-
bidity. Secondly, the co-insurance marks the amount of
OOPP the beneficiary has to spend after the deductible
limit is reached. The insurer only pays a stipulated per-
centage share of the costs, while the patient pays for the
rest. Thirdly, and in the focus of this article, there are
direct OOPP for health-care services. Examples are
costs for prescription medications, hospital stays, alter-
native medicine, physiotherapy or home nursing, which
are not covered by insurance policies and have to be
paid by the patients themselves [2]. All three forms of
copayments are suspected to evoke or reinforce inequal-
ities in burdens for beneficiaries, especially regarding
predispositions in education, sex and, foremost, income,
as will be explored in this review. In the USA, copay-
ments have been established for a long time and have
caused a large body of studies, making the USA the
most valuable source for literature. This may give the
opportunity to outline possible future developments in
Europe. The present review gives an overview of the
inequalities of OOPP by the fastest growing population,
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and sex. In the elderly, inequalities are likely to be most
apparent due to extensive use of medical services caused
by age-related morbidity. Purpose of this task is to pro-
vide a basis, serving as foundation for future studies
focusing on the mechanisms causing the described
inequalities.
Methods
Search strategy
As shown in Figure 1, an online PubMed search was con-
ducted to identify studies. Search terms included combi-
nations of the following keywords: “cost sharing"[All
Fields] OR “copay"[All Fields] OR “copayments"[All
Fields] OR “out of pocket"[All Fields] OR “direct pay-
ments"[All Fields] OR “incentive based"[All Fields] OR
“patient charge"[All Fields] OR “prescription charge"[All
Fields] OR “coinsurance"[All Fields] OR “deductible"[All
Fields] OR “extra billing"[All Fields] AND “aged"[MeSH
Terms]. The search process ended on November 9
th,
2009. Studies’ abstracts were examined in detail, and, if
required, extended by a full text revision.
Inclusion and exclusion criteria
Unless separate data analyses were conducted for the 65+
subsamples, studies not limited to the senior population
(defined as 65 years of age or older) were excluded. Only
studies in English and German language based on evalua-
tion of primary data were considered. Finally, articles had
to contain relevant information concerning education,
sex and/or income in relation to out-of-pocket payments
for people 65+ (as illustrated in Figure 1).
Analysis of data
To facilitate comparisons, all cost estimates were
inflated to 2008 US dollars using the Chain Type Price
Figure 1 diagram showing filtering process of literature used.
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Page 2 of 11Table 1 Overview of studies reviewed (in alphabetical order)
Study Sample Study Design Outcomes
Adams, Soumerai, &
Ross-Degnan, 2001a
4439 Medicare
beneficiaries with
hypertension
national longitudinal survey (MCBS 1995);
inferential statistic
Association between types of drug coverage,
consumption & costs per tablet; Findings: income
Blustein, 1995a 4110 female Medicare
beneficiaries
probability survey based on multistage,
stratified cluster sample of Medicare (MCBS
1991-1992); multiple inferential statistic
Use of mammography during first 2 years of
Medicare offered benefit; Findings: income,
education
Blustein, 2000b 4334 Medicare
beneficiaries with
hypertension
nationally-representative face-to-face survey of
Medicare; multiple inferential statistic
Sexual differences in burden for prescription drugs;
Findings: sex
Chandra et al., 2007 70912 CalPers plan
members
Panel of Medicare supplemental plan Members
(CalPers 2000-2003); multiple inferential statistic
Influence & consequences of price elasticity in
patient cost-sharing; Findings: income
Crystal, Johnson,
Harman,
Sambamoorthi, &
Kumar, 2000b
7886 Medicare
beneficiaries
nationally representative survey of Medicare,
stratified, multistage, area probability sample
(MCBS 1995); multiple inferential statistic
Overview on size, distribution & burden of OOPP;
Findings: income, education
Davis, Poisal, Chulis,
Zarabozo, & Cooper,
1999a
12.000 Medicare
beneficiaries
Panel Survey (MCBS 1995); descriptive Overview on sources & extent of drug coverage
among Medicare beneficiaries; Findings: income
Dowd et al., 1994a 2891 Medicare HMO &
fee-for-service members
Survey; multiple inferential statistic Characteristics of Medicare beneficiaries & influence
on choice of health plan; Findings: income
Fahlman, Lynn,
Doberman, Gabel, &
Finch, 2006d
4602 Medicare
beneficiaries
Cross-sectional, retrospective review & 1990
Census data; multiple inferential statistic
Drug spending by disease & demographics in last
year of life; Findings: income
Gellad, Huskamp,
Phillips, & Haas,
2006a
5596 Medicare
beneficiaries
Panel Survey, nationally representative sample
(MEPS-HC 1996-2000); multiple inferential
statistic
Estimation of change of OOPP for drugs after Part
D implementation; Findings: income
Goldman &
Zissimopoulos,
2003b
7836 Medicare
beneficiaries
Cross sectional survey of 4th wave of Panel
survey (HRS 1998); inferential statistic
Examination of OOPP health-care spending;
Findings: income
Guidry, Aday, Zhang,
& Winn, 1998b
593 Texan cancer
patients
analytical cross-sectional survey; inferential
statistic
Prevalence of barriers to cancer treatment;
Findings: income
Hwang, Weller, Ireys,
& Anderson, 2001a
22.326 patients with
chronic condition
cross-sectional survey (MEPS 1996); descriptive Impact of chronic condition & demographics on
OOPP spending; Findings: sex
Klein, Turvey, &
Wallace, 2004i
6535 participants of
AHEAD-study
cross-sectional study of 2nd wave of AHEAD
study 1997; inferential statistic
Reasons for delay in medication use because of
cost; Findings: income, sex
Lapsley, March,
Tribe, Cross, &
Brooks, 2001a
113 patients with
osteo-arthritis in
Australia
prospective-cohort study; inferential statistic OOPP expenditures related to osteo-arthritis;
Findings: sex
McGarry & Schoeni,
2005b
3821 >70 years old
Americans (271
widowers, 3550
married)
national panel survey (2 Waves) (HRS);
descriptive
Financial gap between widowed and married
Elders; Findings: sex
Miller & Champion,
1993a
161 women convenience sample, mailed survey; inferential
statistic
Relationship of patient’s characteristics and
mammography utilization; Findings: income,
education
Mitchell, Mathews,
Hunt, Cobb, &
Watson, 2001a
499 patients with at
least one regular
prescription medication
cross-sectional survey; mutliple inferential
statistic
extent of mismanaging of prescription drugs
among rural Elders; Findings: income
Mojtabai & Olfson,
2003c
10.413 Medicare
beneficiaries
cross-sectional (HRS 2000); multiple inferential
statistic
Association between drug coverage & adherence;
cost-related poor adherence & health outcomes;
Findings: income
Ness, Cirillo, Weir,
Nisly, & Wallace,
2005b
1099 participants of
HRS study
cross-sectional (HRS 2000); inferential statistic Correlates of complementary & alternative
medicine (CAM) utilization among Elders; Findings:
sex
Pourat, Rice,
Kominski, & Snyder,
2000d
15.103 Medicare
beneficiaries
cross-sectional (MCBS 1996); inferential statistic Comparison of supplemental insurances to
examine impact of socioeconomics; Findings:
income, education
Rector & Venus,
2004a
1500 Medicare+Choice
plan beneficiaries
cross-sectional, random sample in eight
Medicare+Choice Plans; inferential statistic
Influence of drug benefits on affordability for
beneficiaries; Findings: income
Rice & Desmond,
2006e
9278 Medicare
beneficiaries
cross-sectional (SIPP 2001); descriptive Number and characteristics of Medicare
beneficiaries excluded from low-income subsidies
because of failed asset test; Findings: education,
sex
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Page 3 of 11Index for Gross Domestic Product (US Census Bureau
2010). The following information was systematically
extracted (see Table 1): authors, year of publication,
sample size indicating the validity of the article (varying
from 113 to 30,791,751 persons), study design, analyzed
outcome, key findings stratified according to income,
education and gender, and confounders controlled for.
Presentation of findings
This review is structured as follows: every socio-demo-
graphic variable has its own chapter describing its asso-
ciation with OOPP. As income contains the most
information, the respective chapter is further structured
by overall expenditures, and their biggest share, pre-
scription drugs. Furthermore, details on impacts like
insurance types or cost-reducing strategies are reported.
After describing the association of education and sex
with OOPP, a conclusion at the end of this review sum-
marizes all findings, confronts them with theories to put
them in scientific perspective, and gives implications.
Results
Reviewed Articles
995 papers were found via PubMed, and 17 papers were
found via bibliographic search in reference lists of eligi-
ble articles, resulting in a total of 1012 studies. After
exclusion of studies not focusing on out-of-pocket pay-
ments for people 65 years of age or older, 217 studies
remained. Out of these, 29 articles remained containing
relevant information concerning education, sex and/or
income in relation to out-of-pocket payments for people
65+ (as illustrated in Figure 1). Included are 11 longitu-
dinal and 18 cross-sectional surveys, of which 9 articles
use the MCBS (Medicare Current Beneficiary Survey),
making it the most utilized source of data. Five studies
are purely descriptive [3-7], while the remaining 24 use
inferential statistics to test differences in out-of-pocket
payments between income, education and gender
g r o u p s .O ft h e s e ,1 4c o n t r o lled for confounders, mean-
ing independent control variables were evaluated (for
respective confounders in articles see columns in Tables
2, 3 and 4). The articles used in this review originate
from 1993-2009, from which 21 were published before
the implementation of the Medicare Prescription Drug,
Improvement, and Modernization Act of 2003, an
important break marking the inclusion of a voluntary
drug benefit (Part D), taking effect in January 2006 [8].
Studies varied in analysis of absolute expenditures and
its relation to income [9-11], or just focusing on the
burden [7,12,13].
Income
Overall expenditures
Concerning absolute expenditures, Goldman et al.[ 9 ]
f o u n dt h a tm e a ny e a r l yO O P Pi n1 9 9 8w e r es l i g h t l y
higher for people with high income (above $49250/year)
than for those with low income (less than $15969/year):
$2821 against $2346. A similar situation can be observed
for high wealth (above $405.554 assets) compared to low
wealth beneficiaries (less than $52.595): $2857 against
$2551. Considering OOPP in relation to income, Crystal
et al. [12] found that in 1995 low-income beneficiaries
had lower absolute payment amounts, but faced a signif-
icantly higher burden. The lowest income quintile is
most affected by high OOPP: in contrast to the top
quintile, they spent 31.5% of their yearly income ($1639)
Table 1: Overview of studies reviewed (in alphabetical order) (Continued)
Riley, 2008b 4000 Medicare
beneficiaries at a time
panel 4 waves (MCBS 1992, 96, 2000, 04);
inferential statistic
Trends in OOPP health-care costs for MediCare
beneficiaries; Findings: income
Rogowski, Lillard, &
Kington, 1997b
996 Elders cross-sectional (PSID 1990); multiple inferential
statistic
Amount & influence of supplemental insurance on
burden of prescription drug OOPP costs; Findings:
income, education, sex
Sambamoorthi,
Shea, & Crystal,
2003b
8814 Medicare
beneficiaries
cross-sectional (MCBS 1997); multiple
inferential statistic
Total and OOPP burden for prescription drugs in
relation to characteristics of elderly population;
Findings: income, education
Saver, Doescher,
Jackson, & Fishman,
2004d
4492 Medicare+Choice
enrollees
cross-sectional survey and administrative data
from Medicare, 2000; multiple inferential
statistic
Relationship between drug benefit status & access
to medications + influence of income; Findings:
income, education
Selden & Banthin,
2003b
5733 (1987), 2549
(1996) >65 years old
beneficiaries
stratified random samples (NMES 1987 and
MPES 1996), longitudinal; descriptive
Amount health-care burden for Elders; Findings:
income, sex
Soumerai et al.,
2006a
13.835 Medicare
beneficiaries
stratified, multistage sample (MCBS 2004),
cross-sectional; multiple inferential statistic
Prevalence of cost-related medication non-
adherence prior to Medicare Part D; Findings:
income
Wei, Akincigil,
Crystal, &
Sambamoorthi,
2006a
76.440 person-years
(30.375 beneficiaries) of
Medicare beneficiaries
longitudinal (MCBS 1992-2000); multiple
inferential statistic
Gender differences in OOPP expenditures & burden
for medication; Findings: sex
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Page 4 of 11compared to 8.5% ($3219) in the top quintile. Selden et
al. [7] confirmed this finding for 1996: while 19.6% of
families living below the poverty line faced expenditures
of at least 40% of their household income, only 4.8% of
those owning 200% of the poverty line and more belong
to this group. When wealth is included as a variable
increasing income and spending possibilities of the 65+
population, Goldman et al. [9] showed that in 1998 the
lowest quartile spent on average 17% of their annual
wealth, while the top quartile only less than 1%. 10% of
the bottom quartile even spent 43% or more in two
years. The development over time supports this argu-
ment. Riley [13] found an overall OOPP increase of
0.7% from 1992 to 2004, which was skewed in regard to
income quartiles: while the highest quartile experienced
ar i s eo f0 . 8 % ,t h es e c o n dl o w e s tq u a r t i l ew a sh a r d e s t
affected by an increase of 2.3%. The lowest quartile is
protected by supportive Medicaid coverage.
Prescription Drugs
Regarding absolute expenditures, Sambamoorthi et al.
[10] found only slight differences in mean OOPP for dif-
ferent income groups in 1997: while those living above
200% of the poverty line faced payments of $447 for
their prescription drugs, those below had to pay $442.
Rogowski et al. [11] calculated out-of-pocket drug
expenditures at $390 for high-, $492 for middle-, and
$850 for low-income beneficiaries. Concerning the bur-
den of prescription drugs use, Rogowski et al.[ 1 1 ]
found that the overall distribution of OOPP was highly
skewed in 1997: 55% of beneficiaries spent 1% or less,
while 1% of patients spent more than 25% of their yearly
household income on prescription drugs. The same
study also shows that the burden of prescription drug
costs for high-income beneficiaries was around 0.6%,
and 1.6% or even 5.9% for middle and low incomes
respectively, resulting in a ten times difference between
income groups. According to Sambamoorthi et al. [10],
nearly 8% of beneficiaries spent more than 10% of their
income on prescription drugs only. While 2.4% of those
living above 200% of the poverty level were concerned,
13.4% of beneficiaries living below this mark were
affected.
Insurance type
In this context, a decisive argument is the type of insur-
ance that can be afforded, identifying income as highest
influence on choice, and therefore finally on OOPP. Fol-
lowing the 1995 MCBS (Medicare Current Beneficiary
Survey), approximately 65% of Medicare beneficiaries
had supplemental, prescription drug covering insurance
[3]. As Dowd et al. [14] point out: those with the lowest
income are most likely the ones not able to afford ade-
quate insurance. Widespread basic Medicare coverage is
the cheapest way to be insured (low premiums), as long
as there are no health expenditures (high deductibles
and co-insurance rates), which is most likely to happen
to exactly these subgroups. Pourat et al. [15] show that
with rising income, the proportion of beneficiaries with
supplemental insurance rises. Among people relying on
basic Medicare fee-for-service, only 5% have yearly
incomes above $32.561, but 17% have incomes under
$13.024. Adams et al. [16] found that state- and
employer-sponsored drug coverage, and therefore lower
OOPP, lead to a higher consumption of clinically essen-
tial drugs. Confirming this finding, Fahlman et al. [17]
found that increasing levels of household income corre-
lated with a 21% increase of prescriptions and a 25%
increase in mean OOPP. The implementation of Medi-
care Part D in 2006 led to comparable absolute savings
for all beneficiaries. Gellad et al.[ 1 8 ]f o u n dt h eo v e r a l l
out-of-pocket costs to decline $237 on average, even
$501 for seniors without employer-sponsored drug cov-
erage. But in relation to income, the Donut Hole is dis-
advantaging those 3.4 million low-income seniors who
reached it in 2007, having the same costs as high-
income beneficiaries, but higher burdens. Considering
this, Medicare Part D is not able to reduce barriers to
adequate medication use.
Cost-reducing strategies
Hence, strategies to reduce costs are prevalent in low-
income layers of society. Many Elders relying on their
prescription drugs take less medication than prescribed,
or do not fill their prescription to save money. This
results in worse health conditions that require further
treatments and therefore higher OOPP in the long run.
Other strategies are accumulation of debt, utilization of
medicine only in emergency cases, or asking practi-
tioners for free samples [19]. This is emphasized by
Klein et al. [8], who found that low-income Elders only
insured by Medicare fee-for-service are much more
likely to economize. 23.3% of the examined beneficiaries
reduce the amount of medication in order not to exceed
their prescription cap, stopping total adherence by as
much as 16.3%. $100 higher costs per month lead to a
10% higher probability of irregular continuation. Regard-
ing insurance coverage, Saver et al.[ 2 0 ]s t r o n g l ya s s o -
ciated income with having a prescription drug benefit.
In 2000, 25% of those without a prescription drug bene-
fit experienced non-adherence, compared to only 17%
owning such. Rector et al. [21] state that in 2002, 38%
of people with a monthly household income below
$1000 economized, while only 17% of those living with
more than $4000 did. Comparable numbers are reported
by Soumerai et al [22] shortly before the implementa-
tion of Medicare Part D: beneficiaries living with less
than $10.000 yearly income showed a non-adherence
prevalence of 14.5%, those with incomes above $40.000
report only 8.7%. For Medicare beneficiaries living with
out-of-pocket drug spending of at least $1000 in 2000,
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Study Key findings Confounders controlled for
Adams, Soumerai, &
Ross-Degnan, 2001a
high income > good insurance > lower OOPP > higher drug
consumption
none
Blustein, 1995a low income > less probability of mammography age, race, education, self-rated health status, total Medicare
Part B reimbursement in 1991, smoking status, living
arrangement
Chandra et al., 2007 low income > high price elasticity > increased hospital visits
due to less prevention
type of insurance plan, age, spending tercile, Charlson
Index, health status
Crystal, Johnson,
Harman,
Sambamoorthi, &
Kumar, 2000b
average OOPP burden: 19% (lowest quintile: 31.5%, top
quintile: 8.5%)
sex, race, age, education, marital status, self-reported health
status, number of medical conditions, number of ADL &
IADL impairments, insurance coverage
Davis, Poisal, Chulis,
Zarabozo, & Cooper,
1999a
high income > best insurance > lowest OOPP none
Dowd et al., 1994a high income > best insurance > lowest OOPP age, sex, marital status, education, living arrangements,
number & proximity of living children, health insurance,
self-reported health condition
Fahlman, Lynn,
Doberman, Gabel, &
Finch, 2006d
high income > high utilization & OOPP race, sex, Charlson Index, age, insurance type
Gellad, Huskamp,
Phillips, & Haas, 2006a
Medicare Part D > general cost decline, but: high incomes
advantaged through lower burden in Donut Hole
race, chronic conditions, insurance coverage
Goldman &
Zissimopoulos, 2003b
high income > high absolute OOPP, but lower burden
(highest quartile: 1% OOPP of income, lowest: 17% (up to
43%); hardest hit: those shortly above limit of Medicaid
support)
none
Guidry, Aday, Zhang, &
Winn, 1998b
disadvantages for minorities (lower income, bad insurance,
higher costs, less treatments)
none
Klein, Turvey, & Wallace,
2004i
low income > bad insurance > high OOPP > less prevention
> more illnesses > more OOPP > more cost-reducing
strategies > high follow-up costs (each +100$/month OOPP
> +10% of unregular use)
none
Miller & Champion,
1993a
high income > high utilization & drug adherence none
Mitchell, Mathews,
Hunt, Cobb, & Watson,
2001a
less income > less medication adherence due to OOPP >
worse health status & less health consciousness > higher
OOPP > less adherence
age, race, education, residential status, health status,
medication profile
Mojtabai & Olfson,
2003c
lower income > less adherence age, sex, race, education, marital status, employment,
insurance coverage
Pourat, Rice, Kominski,
& Snyder, 2000d
low income > less supplemental prescription drug coverage
> high OOPP
none
Rector & Venus, 2004a low income > more cost induced delay or stop of
medication utilization (<$1000 monthly household income:
38%, >$4000: 17%)
none
Riley, 2008b 1992-2004: absolute OOPP up by 22.5%; highest burden:
second lowest quartile > no Medicaid
none
Rogowski, Lillard, &
Kington, 1997b
low income > higher expenditures & higher burden: 5,4-
5,9%, middle income: 1.6%, highest income: 0,6%; insurance
coverage reduces amount spent by 50%; cost distribution
highly skewed: 55% spend 1% or less, 1% spend 25% of
yearly income
age, sex, race, education, residential status, marital status,
insurance coverage, health status
Sambamoorthi, Shea, &
Crystal, 2003b
Absolute OOPP nearly equal, but: low income > higher
burden (+10% burden: <200% of poverty level: 13.4%,
>200%: 2.4%)
sex, race, age, education, marital status, insurance coverage,
self-rated health status, place of residence
Saver, Doescher,
Jackson, & Fishman,
2004d
high income > higher probability of drug benefit (25% vs.
17%) > more adherence
age, race, sex, education, household configuration,
insurance coverage, self-rated health status
Selden & Banthin,
2003b
lower income > higher burden: +40% burden 1987 (1996)
(below poverty line: 20.9% (19.6%), >200% of p.l.: 3.8% (4.8%))
none
Soumerai et al., 2006a low income > less drug adherence (<$10.000 yearly income:
14.5%, >$40.000: 8.7%)
sex, age, race, education, self-rated health status, insurance
coverage
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Page 6 of 11Mojtabai et al. [23] stated that only 6% of those living at
least 400% above the poverty line economized, while
21% below poverty line admitted to doing so.
Education
Several articles refer to education as a significant cause
for differences among older persons and their burden of
OOPP for medical services. The main finding is that the
lower the level of education, the higher the burden
becomes [10-12]. Lower education may lead to lower
income and lack of employer based health programs
[15,20]. Concerning the burden of overall out-of-pocket
costs in 1995, Crystal et al. [12] found that beneficiaries
with college degrees spent 12.8% of their income on
health-care, while those without a high school diploma
s p e n t2 1 . 4 % .F o c u s i n go nb u r d e no fp r e s c r i p t i o nd r u g s
costs only, Rogowski et al. [11] found that beneficiaries
with less than 12 years of education paid 4.5% of their
incomes on prescription drugs in 1990, while those with
more than 12 years of education only 1.6%. As sug-
gested before, this was mainly caused by lower retire-
ment incomes and less prevalence of private insurance.
Sambamoorthi et al. [10] found that 12.1% of those
without a high school diploma had to pay more than
10% of their income on prescription drugs in 1997, but
only 3.9% of seniors with college education had to. Con-
versely, a burden of 0-5% was determined for 56.9% of
those without a high school diploma, while 77.8% of col-
lege graduates belonged to this group. Increments of
education confirm this trend proportionally. Regarding
insurance coverage, Pourat et al. [15] found in 2000 that
the likelihood of an employment-based or MediGap
coverage is raised by better education, while a poor edu-
cation increases the probability of basic Medicare fee-
for-service insurance only, or no coverage at all, leading
to higher OOPP in case of morbidity. Saver et al.[ 2 0 ]
confirmed this observation in 2004: only 39% of those
without coverage faced monthly expenditures below
$50, while 79% of patients with private prescription cov-
erage did. Equivalently, 8% of not-covered beneficiaries
faced more than $100 per month, while nobody of the
second group had to pay this amount. The poorest are
secured by Medicaid, but the ones shortly above the
income limit for eligibility are confronted with cata-
strophic costs that eat up all their savings before Medi-
caid steps in [9]. Another point is the Medicare Part D
asset test, denoting specific income and asset thresholds
set to qualify for low-income subsidies [6]. Those low-
income seniors failing the test mostly have better educa-
tion than those who qualify for subsidies (college degree:
9.7% vs. 4.4%). But because approximately 70% of those
only have incomes less than 135% of the federal poverty
line, and around 50% of them only have assets less than
$35.000 above the allowing thresholds. These assets
would not pay a single year of nursing home care. Com-
pared to beneficiaries without any assets, they have to
deal with higher OOPP without governmental support,
and in relation to those with higher incomes and larger
assets, they have to pay similar OOPP with less means
[6]. Furthermore, a low educational standard is asso-
ciated with lower utilisation of preventive measures. In
various studies [24,25] clarify that a college degree is
highly associated with preventive behaviour like mam-
mography. Not using preventive measures finally leads
to higher OOPP due to worse health status.
Sex
There are certain gender related differences concerning
OOPP. Selden et al. [7] found that in women, preva-
lence of high burden for medical services is significantly
higher than in men for all age groups. For example,
12.2% of females aged 75 years and older faced burdens
larger than at least 40% of after-tax disposable income
in 1996, but only 9.2% of men. Concerning prescription
drugs, in 1995 women had 18% more annual OOPP
than men ($551 vs. $454) [26]. In a longitudinal study
from 1992-2000, Wei et al.[ 2 7 ]f o u n dt h es i m i l a r
inequality ($526 vs. $432) in expenditures. Regarding
the burden of OOPP for prescription drugs, Wei et al.
describe a gender difference of 28% (4.4% vs. 3.2%) [27].
While finding equal absolute OOPP in 1996, Rogowski
et al. [11] approve the finding that women have a higher
relative burden (3.3% vs. 2.8%). Sambamoorthi et al. [10]
found that 9.4% of women faced a burden of at least
10% of their income for OOPP on prescription drugs,
compared to only 5.7% in men. The more distinct the
gender differences in health status and income are, the
higher the difference in burden appears. One reason for
the differences is that women are less likely to be
employed, and thereby generate less wealth. Even if
women pursue a career, on average they have signifi-
cantly lower income than men. Wei et al.s t a t e dt h a ti n
1999 the mean income for women aged at least 65 years
was $19.097, compared to $35.676 for men [27]. 26% of
female Medicare beneficiaries live below the federal pov-
erty line, whereas only 11% of men. Being less often
employed also means fewer possibilities to be covered
by an employer-financed supplemental insurance
(including drug coverage) to protect women from high
burdens for out-of-pocket medical expenses [26]. Aggra-
vating this is the fact that women consume more medi-
cation than men [27], for example for not incurred
complementary and alternative medicine [28]. Consider-
ing that women in general have to pay more out-of-
pocket for medication and special equipment, as Lapsley
et al. illustrate [29], they are more likely to rely on the
aforementioned strategies to reduce costs [8]. Further-
more, gender-specific morbidities like breast cancer
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Page 7 of 11Table 3 Overview of studies concerning EDUCATION (in alphabetical order)
Study Key findings Confounders controlled for
Blustein, 1995a low education > less probability of mammography age, race, income, self-rated health status, total Medicare Part
B reimbursement in 1991, smoking status, living
arrangement
Crystal, Johnson,
Harman, Sambamoorthi,
& Kumar, 2000b
OOPP burden with no high school: 21.4%, college degree:
12.8%
gender, race, age, income, marital status, self-reported health
status, number of medical conditions, number of ADL &
IADL impairments, insurance coverage
Miller & Champion,
1993a
college degree significant for mammography & physician
visits > less OOPP burden in the long-term
none
Pourat, Rice, Kominski,
& Snyder, 2000d
better education > better insurance > less OOPP none
Rice & Desmond, 2006e higher education than lowest income group > income
above Medicaid limit > same OOPP as high income group,
but less education & income; higher OOPP than subsidy
group for having higher education & income
none
Rogowski, Lillard, &
Kington, 1997b
better education > less OOPP burden (higher income,
better insurance): >12 years: 1.6%, <12 years: 4.5%
age, sex, race, income, residential status, marital status,
insurance coverage, health status
Sambamoorthi, Shea, &
Crystal, 2003b
less education > higher OOPP (over 10% of burden without
high school degree: 12.1%, college: 3.9%)
gender, race, age, income, marital status, insurance coverage,
self-rated health status, place of residence
Saver, Doescher,
Jackson, & Fishman,
2004d)
better education > more prescription drug coverage > less
OOPP
age, race, sex, income, household configuration, insurance
coverage, self-rated health status
Table 4 Overview of studies concerning SEX (in alphabetical order)
Study Key findings Confounders controlled for
Blustein, 2000b women > rather poor (26% below poverty line, men: 11%); less
employed > less insurance coverage > higher OOPP (18% higher than
men for drugs)
age, race, education, self-rated health status,
insurance coverage
Fahlman, Lynn,
Doberman, Gabel, &
Finch, 2006d
women > higher OOPP in last year of life ($668 vs. $586) race, income, Charlson Index, age, insurance type
Hwang, Weller, Ireys, &
Anderson, 2001a
women > longer lifespan > higher probability of comorbidities >
higher OOPP
none
Klein, Turvey, &
Wallace, 2004i
women > higher OOPP > more cost-reducing strategies none
Lapsley, March, Tribe,
Cross, & Brooks, 2001a
women > higher OOPP for drugs & devices none
McGarry & Schoeni,
2005b
women > longer lifespan > more widowhood; lowest income quartile
(<$12.000): 70% of income spent in final two years for health-care
(average: 30%); poverty rate: widows 17%, married Elders: 5%
none
Ness, Cirillo, Weir, Nisly,
& Wallace, 2005b
women > more CAM utilization > higher OOPP none
Rice & Desmond,
2006e
women > longer lifespan: partner dies > income plummets >heir
above limit > no subsidies > old-age poverty; of 46% widowers failing
asset test > 46% female
none
Rogowski, Lillard, &
Kington, 1997b
women > equal expenditures, but higher burden (3.3% vs. 2.8%) age, income, race, education, residential status,
marital status, insurance coverage, health status
Sambamoorthi, Shea, &
Crystal, 2003b
women > higher OOPP (over 10% of burden > women 9.4%, men
5.7%)
income, race, age, education, marital status,
insurance coverage, self-rated health status, place
of residence
Selden & Banthin,
2003b
women > higher burden (over 20% of burden 1987 (1996): 19.6%
(19.8%), men: 12.7% (15.9%)
none
Wei, Akincigil, Crystal, &
Sambamoorthi, 2006a
women > lower income, more utilization, higher absolute OOPP,
higher burden; gender-specific illnesses > less generous benefits >
higher OOPP
race, age, marital status, education, place of
residence, poverty status, insurance coverage,
health status
Corrieri et al. International Journal for Equity in Health 2010, 9:20
http://www.equityhealthj.com/content/9/1/20
Page 8 of 11cause higher OOPP, since appropriate health-care plans
have less generous benefits [27]. An additional aspect is
women’s longer life expectancy, thereby producing the
greater likelihood for chronic diseases in general [4]. For
financial issues, it is also relevant that women, due to
their longer lifespan, have a higher probability become a
widow. Those in the lowest income quartile (below
$12.000) pay approximately 70% of their income in
their final two years for health-care, whereas the aver-
age is around 30%, leading to higher poverty rates
(17% vs. 5%). Among other reasons, OOPP in the last
year of the spouses’ life and the loss of the spouses’
income raise the likelihood of old age poverty for
widows by 56% [5]. Rice et al. deliver proof that if
widowed women benefit from an inheritance, they are
very likely to be excluded from needed low-income
subsidies, because their assets exceed the limit Medi-
care Part D foresees, so that the assets first have to be
spent out-of-pocket before the federal government
steps in: 46% of those failing the asset test are
widowed, and almost all are female (~93%) [6].
Discussion
Findings
Most of the reviewed studies describe inequalities in
OOPP for medical services, in relation to diverging
income proportions. The largest amount of OOPP can
be assigned to prescription medications, leading to cost-
induced strategies like non-adherence, implicating
further health problems. This effect is further enhanced
by the widespread lack of preventive measures among
low-income beneficiaries, partly caused by lack of sup-
plemental insurance. This describes women and low-
educated layers of society. Considered as percentage
share, women, lower social and low-income classes are
far heavier affected. While these variables explain a
great part of income inequalities, which finally lead to
inequalities in OOPP, they are also predictors of
inequalities in their own right. For example, being
female and low-educated leads to being employed less
or working in worse paid jobs than higher-educated
people. A cycle of low income, no supplemental insur-
ance, less paid services, worse health and thereby finan-
cially unfeasible need is set in motion. Besides
inequalities associated with lower income, several stu-
dies indicate higher out-of-pocket burdens on a gender-
and education-specific level. Concerning sex, gender-
specific illnesses (like breast cancer or other chronic dis-
eases that are more likely to occur due to a longer life-
span), and higher costs for medications and special
equipment influence the health-care burden without
being associated with income. On the education side,
problems like lower awareness of a healthy lifestyle,
reflecting less use of preventive measures, may
constitute income-independent disadvantages. Further-
more, another effect can be observed: Neuman et al.
[30] show that the implementation of Medicare Part D
in 2006, resulting in a rising number of private insurers,
led to a larger variety of available plans to choose from.
This could have left low-educated beneficiaries in a con-
fusing situation, making it hard to find adequate insur-
ance options trying to face all possibilities and
background information. As public health policy is
unable to influence education’s role in the short-term by
providing information and transparency, possible
approaches to a solution should be based on the strong
correlation of income and education. Thus, appropriate
measures ought to be largely coherent with those for
income and burden, for example income thresholds
according to beneficiaries’ burden. Besides education, an
enhanced preference of low-risk beneficiaries in popular
plans could have been initiated by the insurers, leaving
disadvantaged seniors aside. This could explain why
despite all reform efforts since 2006, the number of
about four million beneficiaries without drug coverage
remains constant up to today. As several studies
reviewed show the importance of access to prescription
drug coverage for the amount of OOPP prior to the
implementation of Medicare Part D in 2006
[10-12,14,17-20,22,23,26,27,31], its initiation should have
settled this problem. But as studies analyzing data after
2006 reveal [8,30,32], details like the “Donut Hole” cov-
erage gap still remain responsible for inequalities. Based
on the studies reviewed, an explanation for inequalities
in OOPP by these factors remains ambiguous. Also,
methodically, the diversity of controlled confounders
could have caused difficulties in comparing results.
Context & theories
To give a starting point for subsequent studies examin-
ing mechanisms causing these inequalities, hereafter, the
findings will shortly be put in conjunction with relevant
theories. The aim is to show what other variables could
cause effects on OOPP inequalities. Mojtabai et al. [23]
demonstrated that severe health problems lead to more
medication, and thereby higher OOPP, resulting in a
higher probability of non-adherence, poorer health and
more hospitalizations, especially for those without sup-
plemental insurance and low income paired with high
OOPP. This summary is quintessential for most of the
findings in this review. The coherence between high
OOPP and non-adherence to medication is observed by
several authors [8,21,22], as well as the association of
cost-induced strategies and worse health outcomes [19].
The intensification of this problem for low-income ben-
eficiaries in a disadvantageous insurance situation is also
evident [22]. As this finding refers to income only, Sam-
bamoorthi et al. [10] put other variables in perspective
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tions may impact actual developments. Parents’ low
income leads to poor education. A corresponding work-
place, which results in low income (and a lack of suffi-
cient assets), leads to a lifestyle detrimental to good
health and preventive measures, which itself leads to
high OOPP that one cannot afford. Reinforcing this
development, inequalities intensify with age. The con-
nection of low education, poorly paid jobs and corre-
sponding income and insurance, is supported by several
studies reviewed [8,25]. Also, coherence is found
between less income and a lack of awareness of health,
reflecting less adherence to medication and preventive
measures [19]. The resulting effect of higher OOPP has
also been demonstrated [15,22]. To put all questioned
variables in perspective, several articles confirm that
being female is an additional aspect worsening the situa-
tion by, for example, lower income and a longer lifespan
[5,6,17,26]. So generally, Sambamoorthi et al.’st h e s i s
can be confirmed. But it also becomes clear that the
variables income, education and gender cannot explain
the whole context independently, as other aspects throw
different light on the argumentation. Ahrens [33] also
identifies overall working-, living- and environmental
circumstances as main influences on health status. He
states that predisposing factors (age, sex, congenital dis-
eases), medical infrastructure (quantity and quality,
financial means), social status (lifestyle, income, educa-
tion) and comprehensive variables (education system,
environmental quality, labour conditions) as individual
and systematic circumstances finally determine the
means to deal with high OOPP. Therefore, it can be
assumed that a concluding bottom line of coherence
cannot be drawn solely on the basis of income, educa-
tion and gender, as numerous other variables seem to
bear an unexplored amount of influence, whose extent
has to be analyzed in future studies.
Approaches to a solution
Finally, a short windup addressing possible approaches
to overcome inequalities in burden will be provided.
Although beneficiaries can influence their situation by,
for example, granting preventive measures a high prior-
ity, their information deficit puts them in a dependent
position. Their state is defined by the physician’sd i a g -
nosis, who profits from the divide in information, com-
petence and a lack of transparency concerning the
iatrogenic costs [33]. This may be a point to exercise
pressure, by developing a system not paying the physi-
cian by the number of measures prescribed, but by the
quality of care, reflecting his patients’ health status.
McCormick et al. [34] found that only 9.1% of US-
physicians probed support the status quo, while reform
proposals like adding tax credits or tax penalties (49.2%)
or single payer NHI programs (41.6%) are favoured.
When raising OOPP is necessary due to fiscal reasons,
it should occur in relation to the patient’si n c o m e .
Chandra et al. further suggest that one regards health
status as a second factor to determine the income-
related limit of cost-sharing in order to protect chroni-
cally ill patients from catastrophic expenditures [31].
The focus should lie on equal burdens, not equal expen-
ditures. By doing so, inequalities could be alleviated.
Another problem to solve is “cream skimming”,t h e
insurer’s selection of low-risk beneficiaries. As this issue
is intensified by an increasing number of plans to
choose from, the variety of plans should be reduced to a
reasonable and transparent extent. Also, the government
could limit the influence of private insurers on the mar-
ket, so that high-income beneficiaries cannot exclude
themselves from the solidarity system, leaving society
socially unbalanced [30]. Additionally, the inequality
problems in connection with the Donut Hole [8,18] and
the Medicare Part D asset test [6] should be identified
as a financial threat. If OOPP have to be imposed to sta-
bilize the budget situation for future tasks, their imple-
mentation should be carefully thought over, with great
importance attached to socially balanced arrangements.
Limitations
Most of the studies included in the review contained a
number of limitations, reflecting in a confined validity of
this article, namely possible biases in inferring causal
relationships from cross-sectional data, response and
recall errors as a potential concern with survey data, the
different approaches of data collection in reviewed sur-
veys, and the reliability of self-reported data used in sev-
eral studies. Further, comparability may be limited due
to diverse confounders controlled for. Also, the impact
of the implementation of Medicare Part D in 2006 and
the effects of its design can not be totally clarified.
Conclusions
As evidently shown in this systematic review, income
has a significant influence on the amount of OOPP rest-
ing on the beneficiary, especially concerning the inequal-
ity of burden manifesting a profound disadvantage for
low-income patients. Not only resulting in unfeasible
financial difficulties, but also in worse health status, this
inequity creates a vicious cycle hard to escape. Secondly,
while most studies found educational and gender
inequalities to be associated with income, there might
also be effects induced solely by education; for example,
an unhealthy lifestyle leading to higher payments for
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effects, like sex-specific illnesses. Based on the consid-
ered studies, an explanation for inequalities in OOPP by
these factors remains ambiguous.
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